Lupin acquires anti-diabetes trademarks from Boehringer Ingelheim to strengthen portfolio EP News Bureau Dec 16, 2024 Lupin expands its diabetes portfolio with the acquisition of GIBTULIO, GIBTULIO MET, and AJADUO trademarks
